Santa Monica
Sherry’s clients include banks, mortgage originators and servicers, mortgage brokers, commercial lenders, bank holding companies, private equity firms, investment advisors, investment managers, finance companies, fintechs, consumer reporting agencies, data brokers, debt collection companies and related service providers.
She is a Certified Information Privacy Professional (CIPP/US), and was a member of the Mortgage Bankers Association’s 2016 class of Future Leaders and the California Mortgage Bankers Association’s 2014 class of Future Leaders.
Prior to joining Orrick, Sherry was a partner at Buckley LLP. She has been an associate in private practice. She also clerked for the Honorable Jeanette J. Clark in the Superior Court of the District of Columbia.
Santa Monica
Sherry’s clients include banks, mortgage originators and servicers, mortgage brokers, commercial lenders, bank holding companies, private equity firms, investment advisors, investment managers, finance companies, fintechs, consumer reporting agencies, data brokers, debt collection companies and related service providers.
She is a Certified Information Privacy Professional (CIPP/US), and was a member of the Mortgage Bankers Association’s 2016 class of Future Leaders and the California Mortgage Bankers Association’s 2014 class of Future Leaders.
Prior to joining Orrick, Sherry was a partner at Buckley LLP. She has been an associate in private practice. She also clerked for the Honorable Jeanette J. Clark in the Superior Court of the District of Columbia.
Silicon Valley
Michael applies his broad experience in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions to each engagement. He has undertaken over 300 venture capital financings raising an estimated $7 billion for his clients, recently assisting Auris Health to raise over $650 million in financings before its sale to J&J for up to $5.75 billion.
He also brings extensive experience negotiating strategic alliances, representing clients in significant collaborations with GSK, Amgen, Schering-Plough, J&J, Daiichi, Astellas, King Pharmaceuticals, and most recently Pfizer, Merck, Baxter and Dainippon Sumitomo Pharma Co., Ltd.
Michael was the lead lawyer on the initial public offerings for Illumina, Neurocrine Biosciences, Cytokinetics, Pain Therapeutics, NeurogesX, Sequana Therapeutics, Ciphergen Biosystems, Argonaut Technologies, and Microcide Pharmaceuticals.
Michael was also the lead lawyer responsible for negotiating many notable biopharmaceutical spin-outs, including Onyx Pharmaceuticals (Chiron-Cetus), Tularik (Genentech), X-Ceptor (Ligand Pharmaceuticals), Metabasis (Gensia Sicor), and as well on the reverse merger of Transcept Pharmaceuticals with Novacea, creating a new publicly traded entity.
Silicon Valley
Michael applies his broad experience in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions to each engagement. He has undertaken over 300 venture capital financings raising an estimated $7 billion for his clients, recently assisting Auris Health to raise over $650 million in financings before its sale to J&J for up to $5.75 billion.
He also brings extensive experience negotiating strategic alliances, representing clients in significant collaborations with GSK, Amgen, Schering-Plough, J&J, Daiichi, Astellas, King Pharmaceuticals, and most recently Pfizer, Merck, Baxter and Dainippon Sumitomo Pharma Co., Ltd.
Michael was the lead lawyer on the initial public offerings for Illumina, Neurocrine Biosciences, Cytokinetics, Pain Therapeutics, NeurogesX, Sequana Therapeutics, Ciphergen Biosystems, Argonaut Technologies, and Microcide Pharmaceuticals.
Michael was also the lead lawyer responsible for negotiating many notable biopharmaceutical spin-outs, including Onyx Pharmaceuticals (Chiron-Cetus), Tularik (Genentech), X-Ceptor (Ligand Pharmaceuticals), Metabasis (Gensia Sicor), and as well on the reverse merger of Transcept Pharmaceuticals with Novacea, creating a new publicly traded entity.
New York
Alyssa navigates clients through privacy programs and policy creation, and provides guidance on compliance with federal, state and international laws and regulations, including the U.S. state privacy laws in California, Colorado, Connecticut, Utah, Virginia and other states, the General Data Protection Regulation (GDPR), the Federal Trade Commission Act (FTC Act), the Health Insurance Portability and Accountability Act (HIPAA) and state data breach notification laws. She advises clients on security incident response and federal and state investigations related to privacy and data security. She also provides assessments of privacy and security practices for companies carrying out due diligence in the context of corporate transactions.
New York
Alyssa navigates clients through privacy programs and policy creation, and provides guidance on compliance with federal, state and international laws and regulations, including the U.S. state privacy laws in California, Colorado, Connecticut, Utah, Virginia and other states, the General Data Protection Regulation (GDPR), the Federal Trade Commission Act (FTC Act), the Health Insurance Portability and Accountability Act (HIPAA) and state data breach notification laws. She advises clients on security incident response and federal and state investigations related to privacy and data security. She also provides assessments of privacy and security practices for companies carrying out due diligence in the context of corporate transactions.
Austin
Ana's practice focuses on public finance, which includes representing local governments, school districts, and financial institutions that underwrite bonds. She represents her clients in a range of public finance matters, such as general obligation and revenue bonds and public improvement districts.
Austin
Ana's practice focuses on public finance, which includes representing local governments, school districts, and financial institutions that underwrite bonds. She represents her clients in a range of public finance matters, such as general obligation and revenue bonds and public improvement districts.
Seattle
Jason is a member of Orrick's technology companies practice group. He works with both early-stage and late-stage companies and assists with all aspects of formation and venture capital financing. He provides advice to companies seeking exit transactions such as mergers & acquisitions, initial public offerings, or SPAC transactions. Jason also advises investors planning to invest in tech companies in various industries and markets.
Prior to joining Orrick, Jason served in the U.S. Army as an Infantry officer and as a Military Intelligence officer.
Seattle
Jason is a member of Orrick's technology companies practice group. He works with both early-stage and late-stage companies and assists with all aspects of formation and venture capital financing. He provides advice to companies seeking exit transactions such as mergers & acquisitions, initial public offerings, or SPAC transactions. Jason also advises investors planning to invest in tech companies in various industries and markets.
Prior to joining Orrick, Jason served in the U.S. Army as an Infantry officer and as a Military Intelligence officer.
San Francisco
As a Senior Associate in Orrick’s Technology Companies Group, Andrew leverages his experience as a general counsel, operator and investor to guide clients through all stages from startup to exit. He is a trusted advisor on board governance, venture capital transactions, general employment and commercial matters, conflict resolution, mergers & acquisitions and public offerings. Andrew also counsels venture funds in structuring deals and assists them in identifying and managing the various risks associated with their investments.
Prior to re-joining Orrick in 2022, Andrew was employee number 2 at a venture-backed food technology/CPG startup where, in addition to acting as General Counsel, he established the finance, accounting, HR and operations management functions of the company and served on the executive management team responsible for defining and executing the company’s strategic initiatives.
Andrew began his legal career as an associate with Orrick’s Technology Companies Group in 2016 and is the recipient of the Firm’s 2019 Alan Talkington Mentorship Award. He also has experience working for venture funds and technology startups and is an active angel investor.
Andrew lives in Colorado with his wife, daughter and labradoodle. In his spare time, you can often find him hiking, fly fishing and skiing.
San Francisco
As a Senior Associate in Orrick’s Technology Companies Group, Andrew leverages his experience as a general counsel, operator and investor to guide clients through all stages from startup to exit. He is a trusted advisor on board governance, venture capital transactions, general employment and commercial matters, conflict resolution, mergers & acquisitions and public offerings. Andrew also counsels venture funds in structuring deals and assists them in identifying and managing the various risks associated with their investments.
Prior to re-joining Orrick in 2022, Andrew was employee number 2 at a venture-backed food technology/CPG startup where, in addition to acting as General Counsel, he established the finance, accounting, HR and operations management functions of the company and served on the executive management team responsible for defining and executing the company’s strategic initiatives.
Andrew began his legal career as an associate with Orrick’s Technology Companies Group in 2016 and is the recipient of the Firm’s 2019 Alan Talkington Mentorship Award. He also has experience working for venture funds and technology startups and is an active angel investor.
Andrew lives in Colorado with his wife, daughter and labradoodle. In his spare time, you can often find him hiking, fly fishing and skiing.